| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/03/2013 | CN103012281A Racemization method of chiral 2-[(4, 6-sulfamethzaine-2-yl) oxygroup]-3-methoxy-3,3-diphenyl propionic acid |
| 04/03/2013 | CN103012280A Method for preparing ambrisentan |
| 04/03/2013 | CN103012279A Preparation method of 4,5,6-trifluoro-pyrimidine compound |
| 04/03/2013 | CN103012278A Synthesizing method of 4-chloro-2,6-dimethyl-pyrimidine |
| 04/03/2013 | CN102079726B Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound |
| 04/03/2013 | CN101979394B A method to inhibit ethylene responses in plants |
| 04/03/2013 | CN101781157B Mono-iodo-substituted synthetic method for preparing aromatic or heteroaromatic compound |
| 04/03/2013 | CN101538230B Beta-amino ketones compound with anti-diabetic activity |
| 04/03/2013 | CN101516834B Isoserine derivatives for use as coagulation factor IXa inhibitors |
| 04/02/2013 | US8410266 2,4-pyrimidinediamine compounds and their uses |
| 04/02/2013 | US8410155 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIA inhibitors |
| 04/02/2013 | US8410124 Deuterated etravirine |
| 04/02/2013 | US8410116 Bis(styryl)pyrimidine or bis(styryl)benzene compounds, pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition for prevention or treatment of diseases featuring amyloids comprising the same as an active ingredient |
| 04/02/2013 | US8410115 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
| 04/02/2013 | US8410093 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 04/02/2013 | CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 04/02/2013 | CA2550843C Novel phenylalanine derivatives |
| 03/28/2013 | WO2013040789A1 Substituted pyrimidines |
| 03/28/2013 | WO2012146736A8 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
| 03/28/2013 | US20130079519 Regioselective preparation of substituted pyrimidines |
| 03/28/2013 | US20130079518 Regioselective preparation of substituted pyrimidines |
| 03/28/2013 | US20130079517 Electroluminescent Device |
| 03/28/2013 | US20130079361 Novel iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (mif)-implicated diseases and conditions |
| 03/28/2013 | US20130079338 Selective NR2B Antagonists |
| 03/28/2013 | US20130078256 Novel hiv reverse transcriptase inhibitors |
| 03/27/2013 | EP2573559A1 Modulation of chemosensory receptors and ligands associated |
| 03/27/2013 | EP2573074A1 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4- pyrimidinecarboxylates and their use as herbicides |
| 03/27/2013 | EP2571857A1 Novel processes |
| 03/27/2013 | EP2571856A1 Compounds |
| 03/27/2013 | CN103003250A Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 03/27/2013 | CN103003249A Novel processes |
| 03/27/2013 | CN102993105A 1-methyl-2, 4-quinazoline diketone derivative and preparation method and application thereof |
| 03/27/2013 | CN102993104A Preparation method of sulphadimethoxine sodium |
| 03/27/2013 | CN102993103A N1, N3-dialkyl substituted 3, 4-dihydropyrimidine-2 ketone derivative and preparation method thereof |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN101863843B Method for producing dihydroquinazolines |
| 03/27/2013 | CN101809002B Morpholino pyrimidine derivatives used in diseases linked to MTOR kinase and/or PI3K |
| 03/27/2013 | CN101296907B Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 03/27/2013 | CN101243056B Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 03/27/2013 | CN101146786B Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/26/2013 | US8404841 Process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 03/26/2013 | US8404840 Process for the preparation of endothelin receptor antagonists |
| 03/26/2013 | US8404700 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 03/26/2013 | US8404698 Quinazoline derivatives and therapeutic use thereof |
| 03/26/2013 | CA2591439C Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof |
| 03/21/2013 | WO2013040044A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/21/2013 | WO2013038425A1 Rilpivirine hydrochloride |
| 03/21/2013 | WO2013038153A1 18f-labelled barbiturate compounds for use as positron emission imaging agents |
| 03/21/2013 | WO2013037942A1 Synthesis of triazolopyrimidine compounds |
| 03/21/2013 | WO2013037896A1 Disubstituted 5-fluoro-pyrimidines |
| 03/21/2013 | WO2013037894A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
| 03/21/2013 | WO2012143937A3 Process for preparation of rilpivirine intermediate |
| 03/21/2013 | US20130072503 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 03/21/2013 | US20130072487 Prolyl hydroxylase inhibitors |
| 03/21/2013 | US20130072486 Pyrimidine cyclohexyl glucocorticoid receptor modulators |
| 03/21/2013 | US20130072469 Heteroaryl compounds and uses thereof |
| 03/21/2013 | DE202012011888U1 Kristallines Mehrkomponentensystem von Rosuvastatin-Calciumsalz und Vanillin Crystalline multicomponent system of rosuvastatin calcium salt and vanillin |
| 03/21/2013 | CA2848631A1 Rilpivirine hydrochloride |
| 03/21/2013 | CA2848621A1 Synthesis of triazolopyrimidine compounds |
| 03/21/2013 | CA2848616A1 Disubstituted 5-fluoro-pyrimidines |
| 03/21/2013 | CA2848615A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
| 03/21/2013 | CA2848540A1 Therapeutic compounds |
| 03/21/2013 | CA2844704A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/20/2013 | EP2570405A1 Synthesis of Triazolopyrimidine Compounds |
| 03/20/2013 | EP2569288A2 4,6-dibenzoylamino-2-methyl-pyrimidine derivatives and their use for the treatment of cancer |
| 03/20/2013 | EP2569287A2 Compounds useful as inhibitors of atr kinase |
| 03/20/2013 | EP2569263A1 A thionation process and a thionating agent |
| 03/20/2013 | CN1302801B Substituted aminoquinazolone (thio-ketone) derivative or its salt, its intermediate and pest controlling agent and its application method |
| 03/20/2013 | CN102977036A 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides |
| 03/20/2013 | CN102977035A Method for synthesizing 2-methyl-4-hydroxyl-5-hydroxymethyl pyrimidine |
| 03/20/2013 | CN102174023B Preparation method of hydroxyl pyridine compound |
| 03/20/2013 | CN101778830B Particulates of a crth2 antagonist |
| 03/20/2013 | CN101687819B Novel preparation for external use |
| 03/20/2013 | CN101429164B Levorotation benzhydryl piperazidine derivant and preparing method thereof |
| 03/20/2013 | CN101370792B Bi-aryl meta-pyrimidine inhibitors of kinases |
| 03/20/2013 | CN101039920B 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 03/19/2013 | US8399683 IAP inhibitors |
| 03/19/2013 | US8399667 4-anilino quinazoline derivatives as antiproliferative agents |
| 03/19/2013 | US8399655 Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1′-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof |
| 03/19/2013 | US8399472 e.g. 5-Fluoro-N4-(3-hydroxyphenyl)-N2-[4-(N-methyl)aminosulfonyl-3-methoxyphenyl]-2,4-pyrimidinediamine; tyrosine (JAK) kinases inhibitor; interleukin and tumor necrosis factor ligand; transplant rejection; T-cell mediated autoimmune disease |
| 03/19/2013 | US8399461 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
| 03/19/2013 | US8399450 Compounds and compositions as protein kinase inhibitors |
| 03/19/2013 | US8399448 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis |
| 03/19/2013 | US8399381 Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same |
| 03/19/2013 | CA2682629C Pyrimidine hydrazide compounds as pgds inhibitors |
| 03/14/2013 | WO2013036748A1 Bicyclo[6.1.0]non-4-yne reagents for chemical modification of oligonucleotides |
| 03/14/2013 | WO2013036224A1 Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy |
| 03/14/2013 | WO2013035827A1 Novel olefin derivative |
| 03/14/2013 | WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease |
| 03/14/2013 | US20130066074 Process for the preparation of propenal intermediate and derivatives thereof |
| 03/14/2013 | US20130066073 Process for the preparation of dihydroquinazolines |
| 03/14/2013 | US20130066072 Crystals of salts of phenylalanine derivatives |
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130065912 Pesticidal compositions |
| 03/14/2013 | US20130065879 Heteroaryl compounds and uses thereof |
| 03/14/2013 | DE102011112978A1 Benzonitrilderivate Benzonitrile derivatives |
| 03/14/2013 | CA2846503A1 Use of 1h-quinazoline-2,4-diones for use in the prevention or treatment of photosensitive epilepsy |
| 03/13/2013 | EP2566859A2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same |
| 03/13/2013 | CN1938244B Fluoridation method |
| 03/13/2013 | CN102971301A 6 - methyl - 4 - phenyl - 5 - ( phenyl or cycloalkyl) carbamoyl - 1,2,3, 4 - tetrahydropyrimidin- 2 - one derivatives as antitubercular agents |